PT99081A - Processo de preparacao de derivados de fenilpiridinol, de seus intermediarios e de composicoes farmaceuticas que os contem - Google Patents

Processo de preparacao de derivados de fenilpiridinol, de seus intermediarios e de composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT99081A
PT99081A PT99081A PT9908191A PT99081A PT 99081 A PT99081 A PT 99081A PT 99081 A PT99081 A PT 99081A PT 9908191 A PT9908191 A PT 9908191A PT 99081 A PT99081 A PT 99081A
Authority
PT
Portugal
Prior art keywords
pyridin
tetrazolyl
methoxy
cyano
starting
Prior art date
Application number
PT99081A
Other languages
English (en)
Portuguese (pt)
Inventor
Kenneth John Murray
Roderick Alan Porter
Hunter Douglas Prain
Brian Herbert Warrington
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909021184A external-priority patent/GB9021184D0/en
Priority claimed from GB919117657A external-priority patent/GB9117657D0/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PT99081A publication Critical patent/PT99081A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
PT99081A 1990-09-28 1991-09-26 Processo de preparacao de derivados de fenilpiridinol, de seus intermediarios e de composicoes farmaceuticas que os contem PT99081A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909021184A GB9021184D0 (en) 1990-09-28 1990-09-28 Chemical compounds
GB919117657A GB9117657D0 (en) 1991-08-15 1991-08-15 Chemical compounds

Publications (1)

Publication Number Publication Date
PT99081A true PT99081A (pt) 1992-08-31

Family

ID=26297727

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99081A PT99081A (pt) 1990-09-28 1991-09-26 Processo de preparacao de derivados de fenilpiridinol, de seus intermediarios e de composicoes farmaceuticas que os contem

Country Status (9)

Country Link
EP (1) EP0550576A1 (ja)
JP (1) JPH06501254A (ja)
AU (1) AU644016B2 (ja)
CA (1) CA2091989A1 (ja)
IE (1) IE913400A1 (ja)
MX (1) MX9101375A (ja)
NZ (1) NZ239946A (ja)
PT (1) PT99081A (ja)
WO (1) WO1992006085A1 (ja)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9124577D0 (en) * 1991-11-20 1992-01-08 Smithkline Beecham Plc Chemical compounds
GB9124578D0 (en) * 1991-11-20 1992-01-08 Smithkline Beecham Plc Chemical compounds
FR2689012A1 (fr) * 1992-03-27 1993-10-01 Beecham Laboratoires Utilisation de composés aryliques dans le traitement d'affections cardio-vasculaires.
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
BR9307570A (pt) * 1992-12-02 1999-05-25 Pfizer Diéteres de catecol como inibidores seletivos de pdeiv
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
ATE260911T1 (de) * 1993-12-22 2004-03-15 Celltech R&D Ltd Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
GB9412573D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412571D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
DE19500760A1 (de) * 1995-01-13 1996-07-18 Basf Ag Substituierte 2-Phenylpyridine
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526246D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9604926D0 (en) * 1996-03-08 1996-05-08 Sandoz Ltd Organic compounds
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9622363D0 (en) * 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
GB9625184D0 (en) * 1996-12-04 1997-01-22 Celltech Therapeutics Ltd Chemical compounds
EP0946523A1 (en) 1996-12-23 1999-10-06 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9705361D0 (en) * 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
RU2330024C2 (ru) 2001-05-29 2008-07-27 Шеринг Акциенгезельшафт Ингибирующие cdk-киназы пиримидины, способ их получения и их применение в качестве лекарственных средств
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
BR112018069001B1 (pt) 2016-03-31 2022-09-06 Sumitomo Chemical Company, Limited Composto heterocíclico e composição e método para controlar o artrópode nocivo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5651488A (en) * 1979-10-02 1981-05-09 Meiji Seika Kaisha Ltd Penicillin derivative and its preparation
GB8809481D0 (en) * 1988-04-21 1988-05-25 Smith Kline French Lab Chemical compounds
GB8923131D0 (en) * 1989-10-13 1989-11-29 Smith Kline French Lab Chemical compounds

Also Published As

Publication number Publication date
CA2091989A1 (en) 1992-03-29
EP0550576A1 (en) 1993-07-14
WO1992006085A1 (en) 1992-04-16
AU644016B2 (en) 1993-12-02
AU8543191A (en) 1992-04-28
IE913400A1 (en) 1992-04-08
NZ239946A (en) 1994-09-27
JPH06501254A (ja) 1994-02-10
MX9101375A (es) 1992-05-04

Similar Documents

Publication Publication Date Title
PT99081A (pt) Processo de preparacao de derivados de fenilpiridinol, de seus intermediarios e de composicoes farmaceuticas que os contem
JP5097701B2 (ja) Ｒｈｏ−キナーゼの阻害剤としてのイソキノリン誘導体
JP7475049B2 (ja) アルコキシベンゾ五員（六員）複素環式アミン化合物およびその医薬用途
JPH09502457A (ja) 置換アザインドリリデン化合物及びその製造方法
JP5901520B2 (ja) ２ｈピリダジン−３−オン誘導体、その製造、およびそれらのｓｃｄ−１インヒビターとしての使用
PT97722A (pt) Processo de preparacao de derivados de aril fenol/piridinol condesados e de composicoes farmaceuticas que os contem
RU2235095C2 (ru) 2,3-дизамещенное производное пиридина, способы его получения, содержащая его фармацевтическая композиция и промежуточный продукт для его получения
US4886806A (en) Flavone-3-carboxylic acids compounds and pharmaceutical compositions containing them
US5688822A (en) Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as inhibitors of 5-lipoxygenase
US4694018A (en) Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives
EP0334119B1 (en) Compounds for inhibiting the biosynthesis of lipoxygenase-derived metabolites of arachidonic acid
JPH035455A (ja) 置換ピロリジン化合物および医薬組成物
Lipinski et al. Bronchodilator and antiulcer phenoxypyrimidinones
JPH0356476A (ja) ジアリールエーテル環状エーテル、その製法及びこれを含有する、ロイコトリエン介在疾患又は医学的状態の治療に使用するための製薬剤組成物
PT101072A (pt) Derivados de piridinol,seu uso e processo de preparacao e composicoes farmaceuticas
EA000061B1 (ru) Замещенные фенильные производные в качестве антагонистов эндотелина
US4654349A (en) Anti-allergic methods using pyrazolo(1,5-A)pyridines
KR102255957B1 (ko) 신규한 디벤조옥사포스피닌 옥사이드 유도체 화합물 및 이를 포함하는 퇴행성 질환의 예방 또는 치료용 약제학적 조성물
JP3694774B2 (ja) フェニルカルボン酸誘導体
HUT50475A (en) Process for producing pyrrolo/1,2-a/imidazole and imidazo/1,2-a/pyridine derivatives and pharmaceutical compositions comprising same as active ingredient
PT89124B (pt) Processo para a preparacao de derivados acilo de hidroxi-pirimidinas
JP2779206B2 (ja) スルフェンアミド誘導体
PT101071A (pt) Fenilpiridinois substituidos, seu uso e processo de preparacao e composicoes farmaceuticos
JP4345509B2 (ja) 医薬組成物
Kuchař et al. The antileukotrienic derivatives and homologues of [(quinolin-2-ylmethoxy) sulfanyl] benzoic acids with reduced lipophilicity

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920408

FC3A Refusal

Effective date: 19981118